Evidence map›Paper›PMID 29845768›Full record

ArticlePhysiological reports2018

Persistent expression of neutrophil gelatinase-associated lipocalin and M2 macrophage markers and chronic fibrosis after acute kidney injury.

Hisako Saito, Tetsuhiro Tanaka, Shinji Tanaka, Yoshiki Higashijima, Junna Yamaguchi, Mai Sugahara, Marie Ito, Lisa Uchida, Sho Hasegawa, Takeshi Wakashima and 2 more

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Monocytes and Macrophages in Kidney Disease and Homeostasis.International journal of molecular sciences · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Sepsis-Associated Acute Kidney Disease.Kidney international reports · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hisako SaitoDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Tetsuhiro TanakaDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Shinji TanakaDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Yoshiki HigashijimaDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Junna YamaguchiDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Mai SugaharaDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Marie ItoDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Lisa UchidaDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Sho HasegawaDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Takeshi WakashimaDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Kenji FukuiDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Masaomi NangakuDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Tokyo, Japan.
The University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent epidemiologic studies revealed a correlation between acute kidney injury (AKI) episodes and the progression to chronic kidney disease (CKD). Although the severity and duration of the initial insult likely predict the development of CKD, information regarding tissue markers predictive of early development of renal fibrosis is limited. We investigated key markers in fibrotic kidney in rats and mice. Seven- to eight-week-old male Sprague-Dawley rats underwent bilateral ischemia-reperfusion injury (IRI). Kidney tissues were collected to determine the markers correlated with the severity of kidney fibrosis. In a separate set, a specific chemokine (C-C motif) receptor 2 (CCR2) inhibitor, RS-102895, was administered to 9-week-old male C57BL/6J mice that underwent unilateral IRI (9.2 mg/kg/day in drinking water for 17 days) to investigate whether blockade of the monocyte chemotactic protein-1 (MCP-1) signaling was sufficient to prevent fibrosis. Among candidate tissue markers, neutrophil gelatinase-associated lipocalin (NGAL) and MCP-1 mRNA expressions were correlated with kidney fibrosis. Studies on macrophage polarity showed that mRNA expression of M2, but not M1 macrophage markers, were correlated with acute-phase serum creatinine and fibrosis. Pharmacological blockade of the MCP-1-CCR2 signaling downregulated CCR2, which was insufficient to improve fibrosis in mouse unilateral IRI model, suggesting that additional, redundant pathways contribute to fibrosis. These findings suggested that tissue NGAL expression and M2 macrophage markers are promising markers that show severity of kidney fibrosis. Mechanistic involvement of these markers in CKD pathogenesis warrant additional investigation.

Indexed as

Acute Kidney InjuryAnimalsBiomarkersCreatinineFibrosisKidneyLipocalin-2MacrophagesMaleMice, Inbred C57BLRats, Sprague-DawleyReceptors, CCR2RNA, MessengerSignal TransductionBiomarkersCreatinineLcn2 protein, ratLipocalin-2Receptors, CCR2RNA, MessengerAKI biomarkerfibrosisischemia-reperfusion injurymacrophage polarity

Identifiers

PMID29845768
PMCPMC5974714
OpenAlexW2806002435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.